6 Questions with Dr. Carlile

6 Questions with Dr.Carlile

6 Questions with Dr.Carlile

An interview with one of the Clinical Trial Network’s 

top performing Neurology researchers

Q: What sparked your interest in clinical research?

A: Clinical research allows me to be at the forefront of neurology so I can enrich my understanding of the conditions affecting our patients and offer them the best care possible.

Q: How did you get started with research?


A: Our multi-specialty practice had established a primary care research base with CTNx and I was able to use their experience to build my own research career.

Q: What were some of the biggest barriers to getting started?

A: Getting our first few studies was the most difficult. We had to convince sponsors that we had the capability and patient population to enroll patients and be good stewards of the protocol. 

Q: Are there any recent studies that you are particularly proud of or made a major impact for your patients?

A: Our pediatric migraine study has highlighted the lack of therapeutic options for that population and has been very rewarding.

Q: If you were to give advice to another doctor looking to get started with clinical research, what advice would you give them?

A: Research is often demanding and requires attention and vigilance. If you have the interest and desire to do clinical research, it can transform your practice and allows you to offer potential treatments and diagnostic options for patients that don’t exist in the surrounding community.

Q: How has working with CTNx made an impact on your research program?

A: CTNx has taken the regulatory and many logistical burdens off of our site and allowed us to focus on the aspects of clinical research we are most passionate about. The connections with sponsors that CTNx offers is invaluable.

Dr. Carlile’s experience in clinical research and dedication to serving patients is truly commendable. Thank you for being part of the Clinical Trials Network and making a significant impact in the neurology world.

– The CTNx Team

Contact us if you are interested in getting involved in clinical trials.

Get in Touch
Linkedin

The Clinical Trials Network (CTNx) Partners with SelectIQ to Revolutionize Patient Recruitment for Clinical Research Sites

The Clinical Trials Network (CTNx) Partners with SelectIQ to Revolutionize Patient Recruitment for Clinical Research Sites

 

The Clinical Trials Network (CTNx) has forged a strategic partnership with SelectIQ to transform patient recruitment for clinical research sites. SelectIQ offers an innovative software that seamlessly integrates with a practice’s Electronic Medical Records (EMR) system, harnessing the power of artificial intelligence to analyze patient records. This technology flags individuals whose medical history aligns with the criteria for participation in a clinical trial, ranking them based on their likelihood of participation.

CTNx enhances this process by providing additional support to research sites. Their team conducts outreach, calling and pre-screening potential study candidates to ensure they meet the necessary qualifications. Utilizing an Institutional Review Board (IRB) approved script, qualified candidates are identified and referred to the research site’s study coordinator for an in-person screening and study enrollment.

Christopher Petek, Chief Operating Officer of The Clinical Trials Network, expressed enthusiasm about the partnership, stating, “Patient enrollment is paramount to the success of any study and research site. We are excited to leverage this cutting-edge technology to empower our research sites, streamlining the identification and enrollment of qualified patients in clinical trials.”

Ethan Bond, Chief Executive Officer of SelectIQ, shared that “SelectIQ empowers healthcare providers to connect their patients with relevant clinical trial opportunities. CTNx is a natural collaborator given their success bringing trials into community healthcare practices. We’re proud to support their important work.”

Research sites keen on optimizing their clinical trial enrollment processes can learn more about CTNx’s offerings by visiting their website at www.thectnx.com or requesting to schedule a live demo through the following online form

 

About CTNx

The Clinical Trials Network (CTNx) is a network of private practice research sites committed to enhancing access and diversity in clinical trials. Since its establishment in 2018, CTNx has facilitated the opening of over 90 research sites spanning various medical specialties, including Gastroenterology, Ophthalmology, Dermatology, Allergy/Immunology, Pulmonology, Neurology/Psychiatry, Cardiology, Rheumatology, Endocrinology, and Women’s Health.

CTNx is renowned for its comprehensive centralized administrative support and its in-house program for identifying and training clinical research coordinators, assisting both novice and seasoned investigators in navigating the clinical trial landscape. For more information, visit www.thectnx.com.

About SelectIQ

SelectIQ is a Provider Activation Platform that reduces burden on healthcare providers who wish to make clinical trial opportunities available to their patients. Founded by industry veterans from data and AI firm Palantir, SelectIQ brings a wealth of expertise in clinical data analytics, security, and governance.

The team has a proven track record of developing robust software solutions for esteemed organizations, including intelligence agencies, academic medical centers, and leading pharmaceutical companies. Notably, SelectIQ’s founders played instrumental roles in crafting the data governance systems safeguarding clinical data within the National Institutes of Health’s COVID research platform and the United Kingdom’s National Health Service (NHS). For more information, visit www.selectiq.com.

Interested in SelectIQ and working with us ? Contact us today!

Get in Touch
Linkedin